Indication: Healthy

A Multicenter, Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly.
A Randomized, Double-blind, Placebo-controlled Phase 2b Study to Assess the Efficacy, Immunogenicity and Safety of an Ad26.RSV.preF-based Regimen in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older.
A Randomised, Double-Blinded Study to Assess Safety, Immunogenicity, and Lot Consistency of Solvay’s Cell Derived Influenza Vaccine.
A Randomized, Observer-Blind with Single-Blind Booster, Multi Centre, Study to Evaluate Safety, Tolerability and Immunogenicity of an Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine at Two Different Formulations in Healthy Adult and Elderly Subjects.
A Phase 2b Study to Determine the Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults aged 18 years and over.
A Data Acquisition Study for the Tournicare Blood Pressure Monitor